Latest Pfizer Stories
PARSIPPANY, N.J., April 1, 2013 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today announced a recommendation to remove certain warning statements and modifications of the instructions for use of nicotine replacement therapy (NRT) products. As leaders in smoking cessation, GlaxoSmithKline (GSK) Consumer Healthcare commends the FDA on this action and believes this is a positive step to help more smokers quit and will work with the FDA to implement these changes to...
Brings Global Experience in Healthcare and Product Strategy to Leading Consultancy NEW YORK, April 1, 2013 /PRNewswire/ -- Drew Holzapfel, a senior healthcare executive with more than 15 years of experience in corporate public affairs, sales and marketing across the pharmaceutical and biotechnology industries, has joined High Lantern Group as a Managing Director in the New York office. Holzapfel is an innovator of progressive programs and strategic partnerships to shape healthcare...
HONG KONG, March 27, 2013 /PRNewswire/ -- EarningForecast.com has issued consensus earnings forecast reports for the following companies: Microsoft (NASDAQ:MSFT), Pfizer (NYSE:PFE), Wells Fargo (NYSE:WFC), AT&T (NYSE:T), Apple (NASDAQ:AAPL), and America Movil SAB de CV (NYSE:AMX). (Logo: http://photos.prnewswire.com/prnh/20130128/HK49017LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report Highlights:...
According to court documents, on March 7th, 2013 a Louisiana woman asked the US Supreme Court to hear her case alleging neurological damage from generic Reglan. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Reglan side effects. San Diego, CA (PRWEB) March 26, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently...
TORONTO, March 26, 2013 /PRNewswire/ - Bontan Corporation Inc. ('the Company") (OTCBB: BNTNF) ("Bontan") is pleased to announce that it has signed a letter of intent with Portage Pharma Ltd., a private limited company formed under the laws of The British Virgin Islands ("Portage") to acquire all the issued and outstanding shares of Portage in exchange for approximately 81.7 million shares of Bontan. Approximately 71.4 million shares of Bontan, equal to the total number of warrants...
Growth Hormone Booster Gaining "Cult" Following in Beauty Industry NEW YORK CITY, March 26, 2013 /PRNewswire/ -- What's the most telltale sign your "anti-aging" regimen is working? Your "pillow wrinkles" disappear faster in the morning. Think about it... the older you get, the longer those wrinkles and marks from your pillow stay pressed into your skin. Why? Because your skin is getting drier and less elastic thanks to decreased levels of collagen and elastin. And many people are...
WAYNE, N.J. and SOUTH SAN FRANCISCO, Calif., March 25, 2013 /PRNewswire/ -- Bayer HealthCare and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) announced today that the Ministry of Health, Labor and Welfare (MHLW) in Japan has approved Stivarga(®) (regorafenib) tablets for the treatment of patients with metastatic colorectal cancer (mCRC). In September 2012, Stivarga was approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with mCRC who have been...
EXTON, Pa., March 25, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, after approximately two months on the market, 37 percent of U.S. rheumatologists have prescribed Pfizer's Xeljanz (tofacitinib) in an average of three of their rheumatoid arthritis (RA) patients. However, nearly 10 percent of the surveyed rheumatologists do not plan on using Xeljanz until it has been on the...
50 MOVING FORWARD concentrates on health, prevention, fitness and fun to foster healthy aging among the Y's fastest growing age group CHICAGO and NEW YORK, March 25, 2013 /PRNewswire/ -- Forget "50 is the new 40" or even "the new 30," age 50 is about moving forward. That's why YMCA of the USA (Y-USA) and Pfizer Inc launched 50 MOVING FORWARD, a healthy living plan designed to motivate adults 50 years and older with fresh ideas about behaviors that experts say are crucial to healthy...
Research Behind hGH Booster Has Experts at Conference Buzzing WASHINGTON, March 25, 2013 /PRNewswire/ -- The Academy of Women's Health's prestigious 21(st) Annual Congress in Washington, D.C. concluded yesterday, and while it was the venue for some of the most cutting-edge women's health research in the world, at this year's conference one of the main highlights was -- believe it or not -- an oral human growth hormone (hGH) booster called SeroVital(TM)-hgh. So why was growth hormone...
Latest Pfizer Reference Libraries
Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...
